BioOutsource is a leading provider of contract testing services to the global biopharmaceutical and biotechnology industry.
Our core offering includes a comprehensive suite of services to support the testing of biologic drugs and vaccines throughout preclinical and manufacturing. In particular, BioOutsource specialise in biosimilar testing services for monoclonal antibodies.
Our scientists possess unrivalled scientific and regulatory expertise to help solve the complex challenges encountered during the development of biosimilars, biologics and vaccines.
At BioOutsource, we assess the quality and safety of biologics, advancing drug candidates through each phase of the drug development pathway by:
- Reduce speed to market – Most comprehensive range of off-the-shelf assays for biosimilar development
- Innovative technical expertise – Industry leading technical expertise in bioanalytical and biosafety testing services. As well as in-house R&D department constantly adding to our testing services
- Quality assurance – Quality driven results and regulatory insight for data generation
- Dedicated client support – Single point of contact for clients with regular updates, support and advice
Our experts and client managers work closely with clients, adding value to the process through scientific insights and regular communication and updates.
Rapidly reveals the factors to consider when using ADCC assays for producing precise biosimilar comparability data Glasgow, UK – November 17, 2015: Sartorius Stedim Biotech (SSB) BioOutsource today announced a new video is now available on-line explaining how to overcome the issues associated with using antibody-dependent cell-mediated cytotoxicity (ADCC) assays. The bite-sized video outlines the More
Offering scientists an opportunity for face-to-face meetings to discuss strategies for accelerating biosimilar development Glasgow, UK – November 12, 2015: Sartorius Stedim Biotech (SSB) BioOutsource today announced its expert technical staff will be speaking at and/or attending BIOLATAM, Biosimilars LATAM and Biosimilars and Biobetters conferences from November 16-19. This will provide developers of biosimilars with More
Presents data on factors that affect the sensitivity of ADCC assays and discusses how to optimise methodology Glasgow, UK – November 10, 2015: Sartorius Stedim Biotech (SSB) BioOutsource today announced a new paper entitled, ‘As easy as ADCC’ has been published in the respected journal, European Biopharmaceutical Review. The article outlines the factors affecting the More